Diagnostic accuracy of procalcitonin in adult non-neutropenic cancer patients with suspected infection: a systematic review and meta-analysis

Overview of attention for article published in BMC Infectious Diseases, March 2024

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (87th percentile)
Good Attention Score compared to outputs of the same age and source (79th percentile)

So far, Altmetric has seen 22 X posts from 21 X users, with an upper bound of 78,143 followers.

RT @37phoenix: 好中球減少のないがん患者の感染症に対してプロカルシトニンは感度57％、特異度75%、CRPは感度67%、特異度73%と大きな違いなし。SR&MA. BMC Infect Dis. 2024;24:278. PMID: 38438974. https…

好中球減少のないがん患者の感染症に対してプロカルシトニンは感度57％、特異度75%、CRPは感度67%、特異度73%と大きな違いなし。SR&MA. BMC Infect Dis. 2024;24:278. PMID: 38438974. https://t.co/qlYE0AWPZM

RT @ABsteward: 🆕️⚡️⚡️Systematic review and meta-analysis Diagnostic accuracy of procalcitonin in adult non-neutropenic cancer patients with…

RT @ABsteward: 🆕️⚡️⚡️Systematic review and meta-analysis Diagnostic accuracy of procalcitonin in adult non-neutropenic cancer patients with…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 18 additional X posts.